Pharmafile Logo
Pharmafocus logo
Advanced Search
J&J image

J&J sees Q2 sales rise

July 17, 2013
Sales and Marketing Elan, J&J, JJ, Q2, Synthes, sales

Johnson & Johnson saw overall sales rise 8.5% year-on-year in the second quarter of 2013, with the US healthcare group …

News
lundbeck image

Lundbeck/Otsuka Alzheimer’s drug improves cognition

July 17, 2013
Research and Development, Sales and Marketing Alzheimer's, Lundbeck, Otsuka

Lundbeck and partner Otsuka have posted positive Phase II results for their experimental Alzheimer’s drug. The latest data show statistically …

News
medicago image

Mitsubishi buys into tobacco production firm Medicago

July 17, 2013
Manufacturing and Production Mitsubishi, Phillip Morris, medicago, tobacco

Mitsubishi Tanabe Pharma has bought a majority stake in Canada’s Medicago, a company which specialises in manufacturing vaccines in tobacco …

News

Eleven hospitals put on notice

July 17, 2013
Sales and Marketing Hunt, Labour, Mid Staffs, NHS, burnham, keogh

There were angry exchanges in the House of Commons yesterday as health secretary Jeremy Hunt announced that 11 hospitals in …

News
winchpharma_lyndon_ceo

WinchPharma appoints new chief executive

July 17, 2013
Manufacturing and Production, Research and Development, Sales and Marketing lyndon nicholson, winchpharma

Healthcare products firm WinchPharma has appointed Lyndon Nicholson as its new chief executive with immediate effect.  Nicholson will replace former …

Appointment
Brain scan image

Dementia rates declining in UK

July 17, 2013
Research and Development, Sales and Marketing Alzheimer's, UK, brain, dementia

A new study has found that the rate of dementia in Britain has decreased over the past two decades, contrary …

News
GSK image

GSK exec admits bribery on live TV

July 16, 2013
Medical Communications, Sales and Marketing China, GSK, bribery, cctv

A senior member of GSK China has appeared on state television admitting the firm’s guilt in the ongoing bribery allegations. …

News
syntaxin image

Ipsen buys Syntaxin

July 16, 2013
Research and Development, Sales and Marketing R&D, ipsen, neurology, syntaxin, tsi

French pharma group Ipsen has snapped up privately-owned UK life sciences firm Syntaxin for an upfront payment of €28 million …

News

Roche ‘considers’ Alexion bid

July 16, 2013
Research and Development, Sales and Marketing Alexion, Orphan, Roche, soliris

Speculation that Roche is considering a bid for rare disease specialist Alexion Pharmaceuticals has unleashed a flurry of comment – …

News

The pharma industry in the public imagination

July 16, 2013
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Adams, image, literary, pharma

Popular culture in both films and literature depict pharma and scientists as part of a nefarious industry, hell bent on …

Feature
pfizer image

NICE rejects Pfizer blood cancer drug

July 16, 2013
Sales and Marketing BMS, CML, NICE, Pfizer, bosulif

NICE is not recommending Pfizer’s blood cancer drug Bosulif due to uncertainties over its cost effectiveness and survival benefit. In …

News

Aesica appoints two new business development managers

July 16, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Aesica, ross, thomas

Contract development and manufacturing organisation Aesica has appointed Sven Thomas and David Ross as business development managers. Under the new …

Appointment

Irish eyes smiling as Pfizer plans $130m investment

July 15, 2013
Manufacturing and Production IDA, Pfizer, cork, grange

The company has said it will spend $100m upgrading its Grange Castle site in Dublin and $30m at Ringaskiddy in …

News
lilly image

Lilly revisits Alzheimer’s drug

July 15, 2013
Research and Development, Sales and Marketing Alzheimer's, lilly, solanezumab

Eli Lilly & Co is to run yet another trial of its Alzheimer’s drug solanezumab, which failed twice in Phase …

News
Roche image

Roche’s Erivedge gains conditional EU approval

July 15, 2013
Sales and Marketing Curis, EU, Erivedge, Roche, Swiss, Zelboraf

Roche’s cancer pill Erivedge has received a conditional European approval for treatment of the most common type of skin cancer. …

News
J&J image

Next generation digital firms for Europe wanted

July 15, 2013
Medical Communications, Sales and Marketing J&J, JJ, digital, innovation

Digital health start-ups from across Europe are being called on to form a part of Johnson & Johnson Innovation’s inaugural …

News
simon_lowth_az

Simon Lowth exits AstraZeneca

July 15, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, simon lowth

AstraZeneca’s chief financial officer and executive director Simon Lowth will leave the firm at the end of October. Lowth has …

Appointment
gsk_angle_1

China releases GSK bribery details

July 15, 2013
Sales and Marketing China, GSK, Gao Feng, bribery

News
boehringer_german_building_at_night_5

FDA approves Boehringer’s lung cancer drug

July 12, 2013
Medical Communications, Sales and Marketing Boehringer, FDA, Roche, Tarceva, afatinib, lung cancer

Boehringer Ingelheim’s late-stage lung cancer drug Gilotrif has received an accelerated FDA approval for patients with a certain genetic mutation. …

News

UK science future looking brighter – survey

July 12, 2013
Research and Development, Sales and Marketing UCB, science

A new survey undertaken by UCB has found that enthusiasm for science in the UK is high, but adds that …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026